Home

Helen Torley, President and CEO: Halozyme Therapeutics HALO Sell · Filed 25/06/24

Trade details

Type
Insider sale
Amount
$1,059,200
Shares · price
20,000 sh · $52.96 a share
Held after
733,719 sh
Trade date
25/06/20
Filed
25/06/24
Days to filing
4 days

Sold 2.7% of holdings

Share of holding sold
2.7%

Halozyme Therapeutics trades, last 26 weeks

What else happened in Halozyme Therapeutics around then

Filed or reported within 30 days of the trade day · 25/05/21~25/07/20

Helen Torley's recent trades

  • Helen Torley

    Planned sale10b5-1 planHalozyme Therapeutics

    $23.7M

    Filed 08/17

  • Helen Torley

    Sell10b5-1 planHalozyme Therapeutics

    $1.1M

    Filed 06/03

  • Helen Torley

    Sell10b5-1 planHalozyme Therapeutics

    $875.6K

    Filed 06/03

  • Helen Torley

    Sell10b5-1 planHalozyme Therapeutics

    $425.1K

    Filed 06/03

  • Helen Torley

    Sell10b5-1 planHalozyme Therapeutics

    $369.2K

    Filed 06/03

Helen Torley, CEO — sold $1.1M of Halozyme Therapeutics HALO · 2.7% of holdings · 10b5-1 plan | Whalegun